Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Frelinger

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Journal of Thrombosis and Haemostasis : JTH|October 26, 2005
Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activityM R Barnard, M D Linden, A L Frelinger, et al.
Endocrine Research Communications|January 1, 1979
Plasma immunoreactive calcitonin in lung cancerB A Roos, A W Lindall, S B Baylin, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1980
Plasma immunoreactive calcitonin in lung cancerB A Roos, A W Lindall, S B Baylin, et al.
Thrombosis and Haemostasis|October 6, 2000
GPIIb-IIIa antagonist-induced reduction in platelet surface factor V/Va binding and phosphatidylserine expression in whole bloodM I Furman, L A Krueger, A L Frelinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1987
Molecular cloning and chemical synthesis of a region of platelet glycoprotein IIb involved in adhesive functionJ C Loftus, E F Plow, A L Frelinger, et al.
Journal of Thrombosis and Haemostasis : JTH|March 21, 2007
Indices of platelet activation and the stability of coronary artery diseaseM D Linden, M I Furman, A L Frelinger, et al.
Journal of Thrombosis and Haemostasis : JTH|October 23, 2012
Modified diadenosine tetraphosphates with dual specificity for P2Y1 and P2Y12 are potent antagonists of ADP-induced platelet activationH Chang, I B Yanachkov, E J Dix, et al.
Journal of Thrombosis and Haemostasis : JTH|January 27, 2005
GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary interventionM I Furman, L A Krueger, M D Linden, et al.
Journal of Thrombosis and Haemostasis : JTH|November 20, 2009
Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosisK Przyklenk, A L Frelinger, M D Linden, et al.
Journal of Thrombosis and Haemostasis : JTH|September 28, 2006
Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance'A D Michelson, M D Linden, M I Furman, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Thrombosis and Haemostasis : JTH|October 26, 2005
Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activityM R Barnard, M D Linden, A L Frelinger, et al.
Endocrine Research Communications|January 1, 1979
Plasma immunoreactive calcitonin in lung cancerB A Roos, A W Lindall, S B Baylin, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1980
Plasma immunoreactive calcitonin in lung cancerB A Roos, A W Lindall, S B Baylin, et al.
Thrombosis and Haemostasis|October 6, 2000
GPIIb-IIIa antagonist-induced reduction in platelet surface factor V/Va binding and phosphatidylserine expression in whole bloodM I Furman, L A Krueger, A L Frelinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1987
Molecular cloning and chemical synthesis of a region of platelet glycoprotein IIb involved in adhesive functionJ C Loftus, E F Plow, A L Frelinger, et al.
Journal of Thrombosis and Haemostasis : JTH|March 21, 2007
Indices of platelet activation and the stability of coronary artery diseaseM D Linden, M I Furman, A L Frelinger, et al.
Journal of Thrombosis and Haemostasis : JTH|October 23, 2012
Modified diadenosine tetraphosphates with dual specificity for P2Y1 and P2Y12 are potent antagonists of ADP-induced platelet activationH Chang, I B Yanachkov, E J Dix, et al.
Journal of Thrombosis and Haemostasis : JTH|January 27, 2005
GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary interventionM I Furman, L A Krueger, M D Linden, et al.
Journal of Thrombosis and Haemostasis : JTH|November 20, 2009
Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosisK Przyklenk, A L Frelinger, M D Linden, et al.
Journal of Thrombosis and Haemostasis : JTH|September 28, 2006
Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance'A D Michelson, M D Linden, M I Furman, et al.
Pageof 6